mRNA |
BMS-754807 |
CTRPv2 |
pan-cancer |
AAC |
0.096 |
0.005 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.098 |
0.005 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.099 |
0.006 |
mRNA |
BRD6340 |
CTRPv2 |
pan-cancer |
AAC |
0.093 |
0.007 |
mRNA |
Irinotecan |
gCSI |
pan-cancer |
AAC |
-0.15 |
0.007 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.097 |
0.007 |
mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.094 |
0.008 |
mRNA |
tacrolimus |
CTRPv2 |
pan-cancer |
AAC |
0.092 |
0.009 |
mRNA |
Panobinostat |
CTRPv2 |
pan-cancer |
AAC |
0.087 |
0.009 |
mRNA |
tandutinib |
CTRPv2 |
pan-cancer |
AAC |
0.094 |
0.009 |